Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 14;4(11):103872.
doi: 10.1016/j.jscai.2025.103872. eCollection 2025 Nov.

Angiography-Derived Versus Coronary Guidewire-Derived Index of Microcirculatory Resistance in Patients With Ischemia With Nonobstructive Coronary Arteries

Affiliations

Angiography-Derived Versus Coronary Guidewire-Derived Index of Microcirculatory Resistance in Patients With Ischemia With Nonobstructive Coronary Arteries

Ethan Loftspring et al. J Soc Cardiovasc Angiogr Interv. .

Abstract

Background: Coronary function testing (CFT) during invasive coronary angiography is guideline-recommended to identify coronary microvascular dysfunction (CMD) in patients with ischemia with nonobstructive coronary arteries (INOCA). Wire-free, angiography-derived index of microcirculatory resistance (IMRangio) measurements have been developed to simplify assessment for CMD. We assessed the validity of IMRangio compared with the conventional index of microcirculatory resistance (IMR) in a cohort of individuals with INOCA.

Methods: This single-center observational study prospectively enrolled adults aged >18 years who were referred for clinically indicated invasive coronary angiography for the evaluation of chest discomfort or an anginal equivalent and had no coronary artery lesions with ≥50% stenosis. Participants underwent invasive CFT using bolus thermodilution techniques to determine IMR and coronary flow reserve (CFR) in the left anterior descending artery. IMRangio was calculated retrospectively, blinded to CFT results. CMD was defined by IMR ≥25 or CFR <2.5.

Results: Among 122 enrolled participants with INOCA (median age 62 years, 77% women), the median IMR in the left anterior descending artery was 20 (13-27), CFR was 3.95 (2.5-4.7), and 54 participants (44%) had CMD. IMRangio did not correlate with IMR (r = 0.1; P = .14). Mean IMRangio was not different among patients with and without IMR ≥25 (P = .21). IMRangio ≥25 had a sensitivity of 44% and a specificity of 53% in identifying participants with CMD. In sensitivity analyses among participants with cineangiography at 10 to 15 frames per second (r = 0.37; P = .02) and limited to participants with both optimal angiographic view and frame rates ≥10 (r = 0.48; P = .03), we observed weak positive correlations between IMRangio and IMR.

Conclusions: In patients with INOCA, correlations between IMRangio and IMR were poor. IMRangio appears unreliable for identifying CMD in patients with INOCA.

Keywords: coronary function testing; coronary microvascular dysfunction; diagnostics; ischemia with nonobstructive coronary arteries; microcirculation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency distributions index of microcirculatory resistance (IMR) in all participants. (A) Wire-based index of microcirculatory resistance (IMR) and (B) angiography-derived IMR (IMRangio).
Central Illustration
Central Illustration
In a real-world cohort of 122 patients with ischemia and nonobstructive coronary arteries, there was no correlation between wire-based index of microcirculatory resistance (IMR) and angiography-derived IMR (IMRangio) (r = 0.10; P = .14). AUC, area under the receiver operating characteristic curve; QFR, quantitative flow ratio.
Figure 2
Figure 2
Diagnostic accuracy of angiography-derived index of microcirculatory resistance (IMRangio) to predict the index of microcirculatory resistance (IMR). (A) Diagnostic accuracy in all participants (sensitivity = 51%, specificity = 56%). (B) Diagnostic accuracy in participants with optimal views (sensitivity = 62%, specificity = 51%). (C) Diagnostic accuracy in participants with frame rates of 10 or 15 frames per second (C) (sensitivity = 71%, specificity = 50%). (D) Diagnostic accuracy in participants with optimal views and frame rates ≥10 frames per second (sensitivity = 64%, specificity = 30%).
Figure 3
Figure 3
Receiver operating characteristic (ROC) curves for angiography-derived index of microcirculatory resistance (IMRangio) to estimate abnormal index of microcirculatory resistance (IMR). (A) ROC curve for all participants (area under the ROC curve [AUC] = 0.57, P = .21) with an optimal dichotomous index of IMRangio = 21.9 (sensitivity = 73%, specificity = 44%). (B) ROC curve for participants with optimal views (AUC = 0.63, P = .1) with an optimal dichotomous index of IMRangio = 21.9 (sensitivity = 90%, specificity = 37%). (C) ROC curve in participants with frame rates of 15 or 10 frames per second (AUC = 0.66, P = .13) with an optimal dichotomous index of IMRangio = 21.4 (sensitivity = 93%, specificity = 50%). (D) ROC curve in participants with both optimal views and frame rates ≥10 frames per second (AUC = 0.56, P = .62) with an optimal dichotomous index of IMRangio = 19.8 (sensitivity = 91%, specificity = 30%).
Figure 4
Figure 4
Comparison of angiography-derived index of microcirculatory resistance (IMRangio) in participants with normal and abnormal index of microcirculatory resistance (IMR). (A) Analysis of all participants demonstrating a median IMRangio of 23.65 (n = 85) in participants with normal IMR and a median IMRangio of 25.52 (n = 37) in participants with abnormal IMR (P = .21). (B) Analysis of only participants with optimal views demonstrating a median IMRangio of 24.44 (n = 43) in participants with normal IMR and a median IMRangio of 26.12 (n = 21) in participants with abnormal IMR (P = .1). (C) Analysis of participants with frame rates of 10 or 15 frames per second demonstrating a mean IMRangio of 24.24 (n = 18) in participants with normal IMR and a mean IMRangio of 31.41 (n = 14) in participants with abnormal IMR (P = .04). (D) Analysis of participants with both optimal views and frame rates ≥10 frames per second demonstrating a median IMRangio of 27.1 (n = 10) in participants with normal IMR and a mean IMRangio of 27.9 (n = 11) in participants with abnormal IMR (P = .39).
Figure 5
Figure 5
Comparison of angiography-derived index of microcirculatory resistance (IMRangio) in participants with and without coronary microvascular dysfunction (CMD). Analysis demonstrating a median IMRangio of 24.4 (n = 68) in patients without CMD and a median IMRangio of 24.1 (n = 54) in patients with CMD (P = .31)
Figure 6
Figure 6
Receiver operating characteristic curves for angiography-derived index of microcirculatory resistance to estimate coronary microvascular dysfunction defined by abnormal index of microcirculatory resistance or abnormal coronary flow reserve. Area under the receiver operating characteristic curve = 0.53, P = .63.
Figure 7
Figure 7
Correlations between wire-based index of microcirculatory resistance (IMR) and angiography-derived IMR (IMRangio). (A) In participants with optimal views (r = 0.17; P = .1); (B) in participants with frame rates of 10 or 15 frames per second (r = 0.37; P = .02); and (C) in participants with both optimal views and frame rates ≥10 frames per second (r = 0.48; P = .03).
Figure 8
Figure 8
Bland-Altman plot representing the difference between the index of microcirculatory resistance (IMR) and angiography-derived IMR (IMRangio) vs the mean of IMR and IMRangio. Mean difference, 5.1.

References

    1. Reeh J., Therming C.B., Heitmann M., et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J. 2019;40(18):1426–1435. doi: 10.1093/eurheartj/ehy806. - DOI - PubMed
    1. Virani S.S., Newby L.K., Arnold S.V., et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9–e119. doi: 10.1161/CIR.0000000000001168. - DOI - PubMed
    1. Jespersen L., Hvelplund A., Abildstrøm S.Z., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–744. doi: 10.1093/eurheartj/ehr331. - DOI - PubMed
    1. Mehta P.K., Huang J., Levit R.D., Malas W., Waheed N., Bairey Merz C.N. Ischemia and no obstructive coronary arteries (INOCA): a narrative review. Atherosclerosis. 2022;363:8–21. doi: 10.1016/j.atherosclerosis.2022.11.009. - DOI - PMC - PubMed
    1. Gulati M., Cooper-DeHoff R.M., McClure C., et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843–850. doi: 10.1001/archinternmed.2009.50. - DOI - PMC - PubMed

LinkOut - more resources